NVCR Novocure
Novocure (NVCR) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $614.6K.
Where they traded
Last open-market purchase: September 5, 2025 — 1.0 years ago, by Cordova Ashley .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Leonard Frank X | Chief Executive Officer | Sell | 34,273 | $17.93 | $614.6K | 459,520 −6.9% of holding | |
| HILLEMAN JERYL L | Director | Sell | 2,945 | $15.77 | $46.4K | 13,861 −17.5% of holding | |
| LEUNG GABRIEL | Director | Sell | 2,945 | $15.77 | $46.4K | 89,499 −3.2% of holding | |
| Hung David | Director | Sell | 2,945 | $15.77 | $46.4K | 20,465 −12.6% of holding | |
| VERNON W ANTHONY | Director | Sell | 2,945 | $15.77 | $46.4K | 197,657 −1.5% of holding | |
| Scannell Timothy J | Director | Sell | 2,945 | $15.77 | $46.4K | 14,288 −17.1% of holding | |
| Ocean Allyson J | Director | Sell | 2,945 | $15.77 | $46.4K | 11,324 −20.6% of holding | |
| Stafford Kristin | Director | Sell | 2,945 | $15.77 | $46.4K | 11,324 −20.6% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.